Moderna Inc. expects to launch a personalized cancer vaccine that it’s developing with Merck & Co. by 2027, one of its top ...

Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following ...

A clinical trial demonstrates that personalised cancer vaccines effectively target mutations in high-risk kidney cancer, ...

A team of Yale researchers recently published promising results from a clinical trial testing the effectiveness of a new ...

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...

President Donald Trump’s pick to lead the National Institutes of Health answered sharp questions in a confirmation hearing ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

A vaccine to prevent breast cancer is showing good results, and moving into the next stage of clinical trials.

The S&P 500 advanced 1.1% on Wednesday, March 5, as the White House announced it would delay tariffs affecting U.S.

The five-year survival rate of people diagnosed with pancreatic cancer is currently 13 percent. Two breakthroughs are ...

The study followed 16 patients, including Barbara Brigham, who joined the trial after a routine scan discovered her ...

A recent CDC report further demonstrates the effectiveness of the HPV vaccine against cervical cancer. HPV is a sexually ...